<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02116075</url>
  </required_header>
  <id_info>
    <org_study_id>SC2626</org_study_id>
    <nct_id>NCT02116075</nct_id>
  </id_info>
  <brief_title>Caudal Corticosteroid vs. Dextrose Injection for Lumbosacral Radicular Pain.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Naveed Natanzi</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Long Beach Healthcare System</source>
  <brief_summary>
    <textblock>
      Study comparing caudal prolotherapy to conventional steroid for chronic low back pain
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain relief as measured by VAS pain scale.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the frequency and amount of opioid use.</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability score as determined by Oswstery questionnaire.</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>no Conditions</condition>
  <arm_group>
    <arm_group_label>Epidural Steroid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>80mg depo-medrol 9mL 1% lidocaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural Prolotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10ml of 5% generic dextrose</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural Prolotherapy</intervention_name>
    <description>caudal injection of 10mL 5% dextrose</description>
    <arm_group_label>Epidural Steroid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural Steroid</intervention_name>
    <description>caudal injection of 1mL 80mg depo-medrol with 9ml of 1% lidocaine</description>
    <arm_group_label>Epidural Prolotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA

          1. Participants must satisfy diagnostic criteria for lumbar radicular pain at L4 nerve
             root level or below with consistent MRI or X ray findings.

          2. Evidence of low back pain base upon one or more of the following:

             i. Lumbar back pain episodes lasting greater than 6 months and current pain level is
             greater than 6/10 on VAS.

             ii. Has received at lest 2 types of ancillary treatment (i.e. physical therapy, oral
             analgesia, acupuncture, etc.)

          3. Men or women age greater than or equal to 18 years.

          4. No significant alcohol use (7 or fewer drinks per week).

          5. Patient has a history of at least 2 failed epidural CS injections.

        EXCLUSION CRITERIA

          1. Treatment risk factors including one or more of the following:

             i. Unstable or symptomatic cardiac complaints ii. Unstable or symptomatic respiratory
             complaints iii. Unable to reliably comprehend the protocol or reliably record data

          2. Pregnancy. A serum pregnancy test must be performed and negative in all women of child
             bearing potential within 2 weeks prior to enrollment.

          3. History of Malignancy

          4. Any medical (i.e. malignancy, infection, thrombo-embolic states, autoimmune disease,
             polyneuropathy) or psychosocial condition that in the opinion of the investigator,
             could jeopardize the subject's participation, and compliance with the study criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Naveed M Natanzi, DO</last_name>
    <phone>8186059333</phone>
    <email>NNATANZI@UCI.EDU</email>
  </overall_contact>
  <location>
    <facility>
      <name>Veteran'S Affairs Healthy System</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NAVEED NATANZI, DO</last_name>
      <email>NNATANZI@UCI.EDU</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2014</study_first_submitted>
  <study_first_submitted_qc>April 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2014</study_first_posted>
  <last_update_submitted>June 1, 2015</last_update_submitted>
  <last_update_submitted_qc>June 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>VA Long Beach Healthcare System</investigator_affiliation>
    <investigator_full_name>Naveed Natanzi</investigator_full_name>
    <investigator_title>Resident Physician</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

